Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-29 @ 11:03 AM
Study NCT ID:
NCT04925934
Status:
COMPLETED
Last Update Posted:
2024-07-23
First Post:
2021-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VIB7734.P2.S1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None